
ãã¡ã€ã¶ãŒç€ŸãCOVIDã¯ã¯ãã³èšåºè©Šéšã«ããã2人ã®å¥³æ§ã®æ»äº¡ã«ã€ããŠéç€ºãæ ã
å èšäºã¯ãã¡ããã/Click here to read the original article.
ãã¡ã€ã¶ãŒç€Ÿã®COVID-19ã¯ã¯ãã³ã®ç·æ¥äœ¿çšæ¿èªã«é¢ããFDAã®ææžãåæããç ç©¶è ãã2åç®ã®æ¥çš®åŸ41æ¥ç®ã«å¿åæ¢ã§æ»äº¡ããã«ã³ã¶ã¹å·å¥³æ§ã®æ€æ»å ±åæžãèŠæ±ããŠããããã¡ã€ã¶ãŒç€Ÿã¯æ»äº¡å ±åã«å¿ èŠãª24æéã§ã¯ãªã37æ¥ãèŠããã
ãã¡ã€ã¶ãŒç€Ÿã®èšåºè©Šéšã«é¢é£ããææžãåæãããã€ãªãŒã¯ã©ãŠãã®ç ç©¶ããŒã ã«ãããšããã¡ã€ã¶ãŒã»ãã€ãªã³ããã¯ç€Ÿã¯ãCOVID-19ã¯ã¯ãã³ã®èšåºè©Šéšã§2人ã®ã¯ã¯ãã³æ¥çš®è ãæ»äº¡ããããšãå ¬è¡šããŠããªãã£ãã
æ»äº¡äºæ ã¯ãç±³åœé£åå»è¬åå±ïŒFDAïŒã2020幎12æã«åã¯ã¯ãã³ã®ç·æ¥äœ¿çšæ¿èªïŒEUAïŒãäžããåã«çºçãããããããFDAããèšåºè©Šéšã«åå ããã«ã³ã¶ã¹å·ã®63æ³ã®å¥³æ§ãšãžã§ãŒãžã¢å·ã®58æ³ã®å¥³æ§ã®æ»äº¡ãæããã«ããææžãå ¬ã«ããã®ã¯ãããããçŽ3幎åŸã®2023幎9æã®ããšã ã£ãã
ãªãŒã¹ãã©ãªã¢ã®éº»é ç§å»ã§åšè¡æã®å»åž«ã§ãããDaily Cloutã代衚ããŠãã¡ã€ã¶ãŒç€Ÿã®ææžãåæããç ç©¶è ã®äžäººã§ããJeyanthi Kunadhasanå士ã¯ãã«ã³ã¶ã¹å·ã®Kris Kobachåžæ³é·å®ã«æžç°¡ãéãã63æ³ã®ã«ã³ã¶ã¹å·å¥³æ§ã®æ»äº¡ã«ã€ããŠèª¿æ»ããããèŠè«ããã
ããããã®2ä»¶ã®æ»äº¡äŸãEUAã®æç¹ã§é瀺ãããŠããã°ãBNT162b2 mRNA COVIDã¯ã¯ãã³ã®ä»å ¥ã«ãã£ãŠæ»äº¡ãæžå°ããªãã£ãããšã瀺ãããã§ãããããšKunadhasanã¯æžç°¡ã«æžããŠããã
6æãã³ããã¯ã¯ãã¡ã€ã¶ãŒç€ŸãæèšŽãããå瀟ã¯COVID-19ã¯ã¯ãã³ã ãå®å šã§å¹æç ããšããŠè²©å£²ããªãããæ¢ç¥ã®ãªã¹ã¯ïŒå¿ççãå¿èçãåŠåš ã®å€±æãæ»äº¡ãå«ãïŒãéå®çãªå¹æã«é¢ããéèŠãªããŒã¿ãé ããå ¬è¡ã欺ãããšããŠããã
2022幎ãé£éŠè£å€æã¯FDAã«å¯Ÿãããã¡ã€ã¶ãŒã»ãã€ãªã³ããã¯è£œCOVID-19ã¯ã¯ãã³ã®èšåºè©Šéšã«é¢é£ããçŽ120äžããŒãžã®ææžãå ¬éããããåœããã
Kunadhasanãåæããææžã«ãããšããã¡ã€ã¶ãŒç€Ÿã¯2020幎12æ10æ¥ã®FDAã®ã¯ã¯ãã³ããã³é¢é£çç©åŠç補å€è«®åå§å¡äŒïŒVRBPACïŒã®äŒè°ã®åã«æ»äº¡äŸãå ¬è¡šããæ©äŒããã£ãããå ¬è¡šããªãã£ãã
ãã¡ã€ã¶ãŒç€Ÿã¯ãŸãã2020幎12æã®ãã¥ãŒã€ã³ã°ã©ã³ãã»ãžã£ãŒãã«ã»ãªãã»ã¡ãã£ã·ã³èªã«æ²èŒãããããã¡ã€ã¶ãŒã»ãã€ãªã³ããã¯ã»ã¯ã¯ãã³ã®ãå®å šæ§ãšæå¹æ§ãã謳ãè«æã®äžã§ã被害è ã®ã¯ã¯ãã³æ¥çš®ãšã¯ç¡é¢ä¿ã®ãå¿èçªç¶æ»ããšåé¡ãããæ»äº¡äŸãå ¬è¡šããªãã£ãã
Kunadhasanã¯The Defenderã«èªã£ãïŒ
ãã«ã³ã¶ã¹å·ã§ã®æ»äº¡ã¯ãEUAã®å ±åæéå ã«çºçãããã®ã§ãããç§ã®æžç°¡ã瀺ãããã«ãå ¬è¡šãããŠããªãã£ããVRBPACã®äŒè°ã§ã¯ããã®æ»ãå ¬è¡šããããããæ©äŒããã£ããã
ããã®æ»ã¯æ€æ»ãŸã§ãããŠãããããããVRBPACäŒè°ã®åã«å ¥æå¯èœã§ãã£ãã¯ãã ãããŸãããé瀺ãããªãã£ãã
The SentinelçŽã«ããã°ããä»ã®ç ç©¶ãå¿ççãå¿èçã®å±éºæ§ã瀺ããŠãããç¹ã«2åç®ã®æ³šå°ã®åŸãç¹ã«25æ³ä»¥äžã®è¥ãç·æ§ã§ããããä»ã®æ£è ã§ãåæ§ã§ããããšãèãããšã2人ã®åå è ãå¿èçºäœã§æ»äº¡ãããšããäºå®ã¯ããéèŠã«ãªã ããšã®ããšã§ããã
Children's Health Defense (CHD)ã®æé«ç§åŠè²¬ä»»è ã§ãããã©ã€ã¢ã³ã»ããã«ãŒå士ã¯ããã¡ã€ã¶ãŒãšFDAã®è¡å㯠ãããèšã£ãŠãäºæè ãã§ãããšThe Defenderã«èªã£ãã圌ã¯èšãïŒ
ãèšåºè©Šéšã®ãã¹ãŠã®æ»äº¡ããŒã¿ã¯ãFDAã«å ¬éãããã ãã§ãªããäžè¬ã«ãå ¬éãããå¿ èŠããããŸãããããã§ãªããã°ããã®è£œåãEUAã§ããããšïŒ»å®å šã«ïŒœæ¿èªããããã®ã§ããããšãã€ã³ãã©ãŒã ãã»ã³ã³ã»ã³ããå®å šã«æ¬ èœããŠããŸããã
ããã¡ã€ã¶ãŒç€Ÿããã¯ã¯ãã³æ¥çš®çŸ€ã§æ»äº¡ãæžå°ãããšåãã€ããã®ã¯ãç¹ã«æªè³ªã§ãããã
ããªãã»ãŠã«ããPh.D.ãDaily Cloutã®CEOããThe Pfizer Papers ãã®èè ïŒ The Pfizer Papers: Pfizer's Crimes Against Humanity "ã®èè ã§ããããªãã»ãŠã«ãå士ã¯ãããã®ææžã¯FDAãæ²»éšåå è ã®æ»äº¡ãäžæ³ã«é èœããããšã瀺ããã®ã§ããããããã®èšé²ã¯mRNA泚å°ãšã®çŽæ¥çãªé¢é£ãæããã«ãããã®ã§ãããããšèªã£ãã
ãã¯ãããµã³å士ãšåœŒå¥³ã®ååãæããã«ãããã®æ°ã®æ¯ãªå¥³æ§ã®æ»ã«ã€ããŠã®è©³çްã¯ãçè«çã«ã¯ã³ããã¯ãæ€æ»å ±åæžãèŠæ±ããåœŒå¥³ã®æ»ã«ã€ããŠã®æ å ±ãæã€ç®æè ã«ã€ã³ã¿ãã¥ãŒããããšãå¯èœã«ãããããããªãããšãŠã«ãã¯èšãã
åŒéããæŸå°ç·ç§å»ã§ããã¡ã€ã¶ãŒç€Ÿã®ææžã調æ»ããããã€ãªãŒã¯ã©ãŠããããŒã ã®ã¡ã³ããŒã§ããã¯ãªã¹ã»ãã©ã¯ãŒãºå士ã¯ããã»ã³ããã«ãçŽã«å¯Ÿããå ¬è¡šãããŠããªã2äººã®æ»ã¯ãèšåºè©Šéšãäžæ¢ãããã®ã«ååãªãã®ã§ãã£ãã¯ãã ãšèªã£ãã
ãæèããèããã°ã確ãã«æ»äº¡äŸã¯å°ãªãã§ãããéåžžãFDAã¯ãããªã調æ»ãè¡ããããŸã§èšåºè©Šéšã®äžæ¢ãèŠè«ããŸãããããŠãå€ãã®å ŽåãïŒãã®ä»¶ãïŒãã®èšåºè©Šéšã®çµæ¢ç¬Šã®ãããªãã®ãªã®ã§ãã
ãããã®æ»ã¯ãFDAããã¡ã€ã¶ãŒ-ãã€ãªã³ããã¯ã»ã¯ã¯ãã³ã«EUAãäžããããšã ãå°ãªããšãé£ããããã§ããã ããšææããããã«ãŒã¯ããæãããªæå®³ãçããåŸã2幎以äžãçµã£ãŠãããã®æ å ±ãå ¬è¡šããããšã¯ç¯çœªçã§ããããã¡ã€ã¶ãŒç€Ÿã¯è²¬ä»»ãè² ãã¹ãã ããšè¿°ã¹ãã
ãŠã«ãã¯ããåŒè·å£«ã§ã¯ãªãããè©æ¬ºãé倱ãéå€±èŽæ»ãé ã«æµ®ãã¶ ããšè¿°ã¹ãã
CHDã®ã·ãã¢ã»ãªãµãŒãã»ãµã€ãšã³ãã£ã¹ãã§ããã«ãŒã«ã»ãžã£ããããŠã¹ããŒå士ã¯ããDefenderãçŽã«æ¬¡ã®ããã«èªã£ããæ¿æ²»æš©åè 㯠ãç§åŠãä¿¡é Œãã ãããšãéžãã ããããã¯ééã£ãŠããã
å ¬è¡šãããŠããªãæ»äº¡äŸãFDAã«EUAãã誀ã£ãåæãã§èš±å¯ãããå¯èœæ§
Kunadhasanæ°ã¯æžç°¡ã®äžã§ãããã¡ã€ã¶ãŒç€Ÿã®èšåºè©Šéšã®BNT162b2ã¯ã¯ãã³æäžçŸ€ã§çºçããã«ã³ã¶ã¹å·ã®æªå ¬è¡šã®åå è ã®æ»äº¡ ãã«æ³šæãåèµ·ããããšè¿°ã¹ãŠããã
Kunadhasanã¯ãDaily Cloutã10æã«2ã€ã®æªå ¬è¡šã®æ»äº¡ã«ã€ããŠã®ã¬ããŒããçºè¡šããããšãææããã
KunadhasanãåŒçšããææžã«ãããšãã«ã³ã¶ã¹å·ã®å¥³æ§ã®æ»äº¡ã¯ã2020幎11æ14æ¥ã®ããŒã¿ã«ãããªãæ¥ã®ããªãåãã«èµ·ããã2020幎12æã®VRBPACäŒè°ã®ã»ãŒ1ã¶æåã«èµ·ãã£ãã
ã«ã³ã¶ã¹å·å¥³æ§ã®åæ€çµæã®å ±åã«ã¯37æ¥éã®é ããããããå¿èçªç¶æ»ããæããã«ãªã£ããšã¯ãããµã³ã¯ææããã
ãæ³šç®ãã¹ãã¯ãEUAçºè¡ãšããéèŠãªå±é¢ã§ãã¯ã¯ãã³æ¥çš®çŸ€ããã®æ»äº¡äŸãšåæ€å ±åãæŒããŠããããšã§ããã¡ã€ã¶ãŒç€Ÿã®èšåºè©Šéšã®å®å šæ§å ±åå šäœã«ã€ããŠéå€§ãªæžå¿µãçããããšã¯ãããµã³æ°ã¯æžç°¡ã®äžã§è¿°ã¹ãŠããã
Kunadhasanæ°ã¯ãŸãããã¡ã€ã¶ãŒç€Ÿã®èšåºè©Šéšãããã³ãŒã«ã«ã¯éç¯€ãªæå®³äºè±¡ã®å ±åã矩åä»ããããŠããããšãåžæ³é·å®ã«äŒããïŒ ããã¡ã€ã¶ãŒç€Ÿã®èšåºè©Šéšãããã³ãŒã«ã§ã¯ãéç¯€ãªæå®³äºè±¡ãå ±åããããšãæ±ããããŠãããã
ãã¥ãŒã€ã³ã°ã©ã³ãã»ãžã£ãŒãã«ã»ãªãã»ã¡ãã£ã·ã³èªã®è«æã«èšåããã¯ãããµã³ã¯ããã®è«æã«ã¯6äººã®æ»äº¡è ïŒã¯ã¯ãã³æ¥çš®ãåããèšåºè©Šéšåå è ã®ãã¡2人ãšãã©ã»ã矀ã®åå è ã®ãã¡4人ïŒã®ã¿ãé瀺ãããŠãããšææããã
ãããã2023幎9æã«çºè¡šãããFDAã®ææžã«ã¯ãããã¡ã€ã¶ãŒã»ãã€ãªãã³ããã¯ç€Ÿã¯ãEUAã®ããŒã¿ã«ãããªãã®ããªãåã«ãBNT162b2矀ã§ããã«2äººã®æ»äº¡ããã£ãããšãç¥ããããŠããããããã®æ»äº¡ã¯FDAã«é瀺ãããªãã£ãããšãç€ºãæ å ±ãå«ãŸããŠããããšã¯ãããµã³æ°ã¯æžããŠããã
ææžã«ããã°ãã«ã³ã¶ã¹å·ã®63æ³ã®å¥³æ§ã¯ãã«ã³ã¶ã¹å·ãã¥ãŒãã³ã«ããAlliance for Multispecialty Research LLCã§ãã¡ã€ã¶ãŒãšãã€ãªã³ããã¯ã®è©Šéšã«ç»é²ããã圌女ã¯2020幎8æ18æ¥ãš9æ8æ¥ã«ã¯ã¯ãã³ã2åæ¥çš®ãã2020幎10æ7æ¥ã«ãé©åãªãã©ããŒã¢ããæ€æ»ãåããã
ã¯ãããµã³ã¯ãããããã®å蚺æéäžããããªãäžéœåãªèšåºäºè±¡ã®èšé²ããªãããšæžããŠããããããã2åç®ã®æäžãã41æ¥åŸã®2020幎10æ19æ¥ãçµé芳å¯ãã2é±éãçµããªããã¡ã«ããã®å¥³æ§ã¯æ»äº¡ããããã®åŸã®æ€æ»ã®çµæãæ»å ã¯ãå¿èçªç¶æ»ãã§ãããã¯ã¯ãã³ãšã¯ç¡é¢ä¿ã§ãã£ãã
ã¯ãããµã³ã¯æžç°¡ã®äžã§ããïŒå ±åæéå ã«çºçããïŒãã®æ»äº¡ã𿀿»çµæãã2020幎12æ10æ¥ã®VRBPACäŒè°ã§å ¬è¡šãããªãã£ãçç±ãç¥ãããšã¯æ¥µããŠéèŠã§ãããšè¿°ã¹ãã
ãã®æžç°¡ã¯ãŸãã58æ³ã®ãžã§ãŒãžã¢å·å¥³æ§ã®æ»äº¡ã«ãçŠç¹ãåœãŠãŠããããã®å¥³æ§ã¯2020幎8æ4æ¥ãš8æ27æ¥ã«ãã¡ã€ã¶ãŒã»ãã€ãªã³ããã¯ç€Ÿã®COVID-19ã¯ã¯ãã³ã2åæ¥çš®ããã圌女ã¯2020幎11æ7æ¥ã«ç¡ç äžã«æ»äº¡ãããKunadhasanã¯ãåœŒå¥³ã®æ»ã ã26æ¥éããŒã¿ã«è¿œå ãããªãã£ã ããšææããã
Kunadhasanã¯ããããã®ççŸãKobachã«æçŽãéããã£ããã«ãªã£ããšThe Defenderã«èªã£ãã
ãå»åž«ãšããŠãèšåºè©Šéšåå è ã®æ»äº¡ãšåæ€ã®éé瀺ã¯ãå»çå«çã«å¯Ÿããé倧ãªèä¿¡è¡çºã§ããã³ããã¯æ°ããã®ããšã«æ³šæãæãããã®ã«ã³ã¶ãŒã³å·æ°ã«èª¬æè²¬ä»»ãæããããããšãé¡ã£ãŠããŸãããšã¯ãããµã³æ°ã¯èªã£ãã
ãã«ã³ã¶ã¹å·æ°ã¯ããã®æžç°¡ã«é¢ããŠã³ããã¯æ°ã«é£çµ¡ãåããè¡åãèµ·ããã¹ãã§ãããä»ã®å·ç¥äºããã¡ã€ã¶ãŒç€Ÿã®ç¯çœªãåå·ã§èª¿æ»ãã远éãã¹ãã§ãããšãŠã«ãæ°ã¯è¿°ã¹ãã
ã³ããã¯æ°ã®ãªãã£ã¹ã¯ãThe Defenderããã®ã³ã¡ã³ãèŠè«ã«çããŠããªãã
èåãªå¿èå°éå»ãmRNA COVID泚å°ã®äžæ¢ãæ±ãã声ã«åå
Kunadhasanã®æžç°¡ã¯ãmRNA COVID-19泚å°ã®ã¢ã©ããªã¢ã ïŒäžæåæ¢ïŒããããã¯å šé¢çãªçŠæ¢ããããŠãã®å®å šæ§ã«é¢ããç¬ç«ãã調æ»ãæ±ãã声ãé«ãŸãäžã§åºãããã
å é±ãè±åœã®èŠå¶åœå±ãšä¿å¥åœå±ã«å®ãŠã11ããŒãžã«åã¶æžç°¡ã®äžã§ãå¿èå°éå»ã®ã¢ã»ã ã»ãã«ããã©å士ããããã声ã«å ãã£ãŠããã
ãCOVID-19 mRNAã¯ã¯ãã³ïŒããã¯æè¡çã«ã¯éºäŒåæ²»çã§ããïŒã«ã¯æ·±å»ãªå®³ãããããããã®äžæ¢ãæ±ããå§åçãªèšŒæ ãããããšãã«ããã©ã¯æžç°¡ã«æžããŠããã
ãã®æžç°¡ã¯ãè±åœäžè¬å»çè©è°äŒã®ãã£ãŒãªãŒã»ããã»ã€CEOãè±åœä¿å¥çã®ãŠã§ã¹ã»ã¹ããªãŒãã£ã³ã°åœåé·å®ãè±åœæé«å»ç責任è ã®ã¯ãªã¹ããã¡ãŒã»ãŠã£ããã£å¿ãè±åœç§åŠç ç©¶ã»é©æ°çã®ãããªãã¯ã»ãã©ã³ã¹å¿å®ã«éãããã
ãã«ããã©ã¯ããããã®åœå±è ã®æ±ºå®ã«ã€ããŠããã¯ã¯ãã³ã®å®å šæ§ã«é¢ããäžæåæ¢ãšç¬ç«ãã調æ»ãæ¯æããªãããšã¯ãå±å®³ãšè æè¡çºã®èšŒæ ãèç©ããŠããããšãèãããšããã¯ãå®è¡äžå¯èœã§ããããšæžããã
ãã®æžç°¡ã¯ãŸããä»å¹Žåãã«ãã«ããã©ãèµ·èããã1,900人ã®å»åž«ã2,000人以äžã®ç§åŠè ãåŠè ãå«ã64,000人以äžã眲åããå顿žãåžæã®åå®ãã«ãèšåããŠããã
ãã®å顿žã¯ãmRNA COVID-19ã¯ã¯ãã³ã®äžæåæ¢ãããã¹ãŠã®COVID-19ã¯ã¯ãã³è£œåã®å®å šæ§ãšæå¹æ§ã®å æ¬çåè©äŸ¡ãããã¯ã¯ãã³è¢«å®³è ã«å¯Ÿããæ©æ¥ãªèªèãšæ¯æŽãããå«çååã®å埩ãããçŸåšã®èŠå¢ã®æ ¹æ¬åå ãžã®å¯ŸåŠ ããæ±ããŠããã
12æ11æ¥ãå»çã³ã¡ã³ããŒã¿ãŒã®ãžã§ã³ã»ãã£ã³ãã«å士ã®YouTubeçªçµã«åºæŒãããã«ããã©æ°ã¯ãã¯ã¯ãã³äžæ¢ãæ¯æãã蚌æ 㯠ãå§åçã§ãã ããšè¿°ã¹ãã
è±åœåœå±ã«æçŽãåºããçç±ã説æãããã«ããã©æ°ã¯ããã£ã³ãã«æ°ã«å¯Ÿãããæ¥å ã¯æªèãæŸã€ä¿å¥æ¿çã«ãšã£ãŠéåžžã«åŒ·åãªæ¶æ¯å€ã§ãããšè¿°ã¹ãè¿ãå°æ¥ãçŸåšã¯ç¡çç¶ã ãã¯ã¯ãã³ã«é¢é£ããçç¶ãçºçããå¯èœæ§ã®ãã人ã ãççºçã«å¢ãããããããªããšèªã£ãã
ãç¡çç¶ã®äººã ã¯ãå¿èçºäœãè³åäžãã¬ã³ã®ãªã¹ã¯ããããšç§ã¯æããŠããŸãããã®åé¡ã«æ¬æ Œçã«åãçµããŸã§ã¯ã3幎åã«æ¥çš®ããã¯ã¯ãã³ã§ããå€ãã®äººã ã被害ãåããããšã«ãªããŸãããšãã«ããã©ã¯èšãã
ãç§ã®è¯å¿ã¯ããã®ãŸãŸé»ã£ãŠè£ã§ãã£ãŠããããšãèš±ããŸãããå»çåŸäºè ãšããŠãç§ãã¡ã¯ãã®åé¡ã«åãçµãå¿ èŠããããŸããã
ãç§ãã¡ããã¹ãããšã¯ãç©äºã®å€åãééããèªããããšãæãããèªåã®èããå€ããããšãã§ãããããª......ãããªæåãäœãããšã§ãããšãã«ããã©ã¯èªã£ãã